Risperidone for children with attention-deficit/hyperactivity disorder and severe behavioral dysregulation: a randomized placebo-controlled assessor-blinded trial
Ezatollah Abbasi, Alireza Abdi, Rana Eskandari. Risperidone for children with attention-deficit/hyperactivity disorder and severe behavioral dysregulation: a randomized placebo-controlled assessor-blinded trial. // BMC Psychiatry. – 2026. – DOI: 10.1186/s12888-026-08433-y. – URL: https://doi.org/10.1186/s12888-026-08433-y
Ezatollah Abbasi, Alireza Abdi, & Rana Eskandari (2026). Risperidone for children with attention-deficit/hyperactivity disorder and severe behavioral dysregulation: a randomized placebo-controlled assessor-blinded trial. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08433-y
Ezatollah Abbasi, et al. “Risperidone for children with attention-deficit/hyperactivity disorder and severe behavioral dysregulation: a randomized placebo-controlled assessor-blinded trial.” BMC Psychiatry, 2026. doi:10.1186/s12888-026-08433-y.
@article{Abbasi2026,
title = {Risperidone for children with attention-deficit/hyperactivity disorder and severe behavioral dysregulation: a randomized placebo-controlled assessor-blinded trial},
author = {Abbasi, Ezatollah and Abdi, Alireza and Eskandari, Rana},
journal = {BMC Psychiatry},
year = {2026},
doi = {10.1186/s12888-026-08433-y},
url = {https://doi.org/10.1186/s12888-026-08433-y}
}